Recombinant Antibody Production

Recombinant Antibody Production

Manufacturing

Information

Transient gene expression (TGE) is the method of choice when it comes to fast production of recombinant antibodies in mammalian systems (HEK and CHO). Using transient expression, you can skip the time-consuming and labor-intensive creation of stable cell lines and receive milligram to gram amounts of your protein of interest within weeks. Within years of research and development we established InVEST, our proprietary system for large-scale transient gene expression in HEK cells. InVEST is a highly optimized system which allows an increase in production up to 80-fold compared to standard systems. InVivo is a well experienced service provider with more than 700 successfully completed TGE projects. We offer you custom recombinant antibody production, exactly tailored to your needs. Service package includes: cDNA synthesis (incl. codon optimization) and cloning into InVivo`s proprietary expression vector Endotoxin-free plasmid preparation Transient transfection of HEK cells One-step purification via protein A affinity chromatography QC services: UV280 nm, Capillary Gel Electrophoreses (CGE), analytical SEC Guaranteed purity ≥ 90% Deliverables: 40 mg of high-quality recombinant antibodies (IgG) LC and HC in synthesis vectors (1-2 μg) Certificate of Analysis
InVivo BioTech Services GmbHInVivo is an ISO-certified German contract manufacturing organization (CMO) with more than 20 years of experience in cell culture and the development and production of monoclonal antibodies and recombinant proteins  for research, diagnostic and pre-clinical use. As an independent service provider, InVivo offers cost-effective outsourcing solutions plus a wide range of different expression systems to meet customer needs. We work with companies worldwide, including major diagnostic companies, research institutes and biopharmaceutical companies. We provide a complete range of antibody services, from antibody optimization and development to protein labelling. For monoclonal antibody production, our capacity ranges from  the milligram to the kilogram scale, and we have experience in the expression of antibodies from all kinds of subclasses and species. Besides mAB production, InVivo also focuses on the expression of recombinant proteins, including difficult-to-express proteins. Therefore we established a proprietary, highly-optimized expression system for transient gene expression in HEK cells, called InVest. This system combines an optimized host cell line, sophisticated vector design, large-scale plasmid preparation, serum-free cultivation media and a novel transfection reagent. InVivo now offers diverse SARS-CoV-2 Antigens in large-scale quantities, which are suitable for the development of highly sensitive IVD kits. Please visit our website for more information: https://www.invivo.de/cell-line-development/sars-cov-2-antigens/ For more details on our complete service portfolio please visit www.invivo.de

Log in

See all the content and easy-to-use features by logging in or registering!